Clinical Trial

Evaluation of the Safety and Efficacy of Live ASCs in the Treatment of Diabetic Foot (FOOTCELL)

Name: Evaluation of the Safety and Efficacy of Live ASCs in the Treatment of Diabetic Foot (FOOTCELL) — clinical trial record (NCT06843122)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FOOTCELL

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The goal of this study is to investigate the safety and efficacy of allogenic mesenchymal stem cells isolated from adipose tissue as the treatment for chronic wounds in diabetic foot syndrome in a double-blinded three armed setup.

Trial Details

NCT Number	NCT06843122
Lead Sponsor	Medical University of Warsaw Collaborators: Medical Research Agency, Poland
Conditions	Diabetic Foot Ulcer
Enrollment	105 participants
Start Date	2025-03-08
Primary Completion	2027-02-28 (estimated)
Study Completion	2027-08-01 (estimated)
Updated on ClinicalTrials.gov	2025-02-24